DK3129037T3 - Onkolytiske koppevirusvektorer - Google Patents
Onkolytiske koppevirusvektorer Download PDFInfo
- Publication number
- DK3129037T3 DK3129037T3 DK15720276.3T DK15720276T DK3129037T3 DK 3129037 T3 DK3129037 T3 DK 3129037T3 DK 15720276 T DK15720276 T DK 15720276T DK 3129037 T3 DK3129037 T3 DK 3129037T3
- Authority
- DK
- Denmark
- Prior art keywords
- oncolytic
- virus vectors
- smallpox virus
- smallpox
- vectors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/249,713 US9687515B2 (en) | 2007-11-19 | 2014-04-10 | Poxviral oncolytic vectors |
| PCT/EP2015/057654 WO2015155263A1 (en) | 2014-04-10 | 2015-04-09 | Poxviral oncolytic vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3129037T3 true DK3129037T3 (da) | 2020-02-03 |
Family
ID=53051793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15720276.3T DK3129037T3 (da) | 2014-04-10 | 2015-04-09 | Onkolytiske koppevirusvektorer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3129037B1 (enExample) |
| JP (1) | JP6657115B2 (enExample) |
| KR (1) | KR102457060B1 (enExample) |
| CN (1) | CN106413726B (enExample) |
| AU (1) | AU2015243297B2 (enExample) |
| CA (1) | CA2943871C (enExample) |
| DK (1) | DK3129037T3 (enExample) |
| ES (1) | ES2768715T3 (enExample) |
| IL (1) | IL247535B (enExample) |
| WO (1) | WO2015155263A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018091680A1 (en) * | 2016-11-18 | 2018-05-24 | Transgene Sa | Cowpox-based oncolytic vectors |
| WO2018182014A1 (ja) * | 2017-03-31 | 2018-10-04 | 久修 緒方 | 腫瘍溶解性ウイルスの増殖方法及び抗腫瘍剤 |
| CA3124773A1 (en) * | 2018-12-28 | 2020-07-02 | Transgene | M2-defective poxvirus |
| CN110747174A (zh) * | 2019-10-30 | 2020-02-04 | 青岛宁逸生物科技有限公司 | 一种用于肿瘤治疗的重组病毒 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364773A (en) | 1991-03-07 | 1994-11-15 | Virogenetics Corporation | Genetically engineered vaccine strain |
| EP0575491B1 (en) * | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US5358866A (en) | 1991-07-03 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| US5856153A (en) | 1994-11-17 | 1999-01-05 | Cayla | Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases |
| FR2777570A1 (fr) | 1998-04-17 | 1999-10-22 | Transgene Sa | Mutant ayant une activite phosphoribosyl transferase |
| AU5446700A (en) | 1999-05-28 | 2000-12-18 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
| WO2004014314A2 (en) | 2002-08-12 | 2004-02-19 | David Kirn | Methods and compositions concerning poxviruses and cancer |
| DK1649023T3 (da) | 2003-07-21 | 2008-10-06 | Transgene Sa | Polypeptid med forbedret cytosindeaminaseaktivitet |
| ES2320157T3 (es) | 2004-11-08 | 2009-05-19 | Transgene S.A. | Kit de partes diseñado para poner en practica un tratamiento atitumoral o antivirico en un mamifero. |
| KR20080084528A (ko) * | 2007-03-15 | 2008-09-19 | 제네렉스 바이오테라퓨틱스 인크. | 종양살상형 백시니아 바이러스 암 치료 |
| JP2010533718A (ja) * | 2007-07-18 | 2010-10-28 | ジェネラックス・コーポレイション | 腫瘍溶解性ウイルス治療に付随する副作用の処置もしくは改善用医薬の製造における化学治療剤の使用 |
| DK2212345T3 (en) | 2007-11-19 | 2016-03-21 | Transgene Sa | Oncolytic poxvirus vectors |
| US20100173013A1 (en) * | 2009-01-08 | 2010-07-08 | Denis Drygin | Treatment of neoplastic disorders using combination therapies |
| CA2709292A1 (en) | 2009-07-10 | 2011-01-10 | The Governors Of The University Of Alberta | Oncolytic viruses and methods for treating neoplastic disorders |
-
2015
- 2015-04-09 KR KR1020167030784A patent/KR102457060B1/ko active Active
- 2015-04-09 EP EP15720276.3A patent/EP3129037B1/en active Active
- 2015-04-09 WO PCT/EP2015/057654 patent/WO2015155263A1/en not_active Ceased
- 2015-04-09 CA CA2943871A patent/CA2943871C/en active Active
- 2015-04-09 ES ES15720276T patent/ES2768715T3/es active Active
- 2015-04-09 CN CN201580018763.1A patent/CN106413726B/zh active Active
- 2015-04-09 DK DK15720276.3T patent/DK3129037T3/da active
- 2015-04-09 JP JP2016561850A patent/JP6657115B2/ja active Active
- 2015-04-09 AU AU2015243297A patent/AU2015243297B2/en active Active
-
2016
- 2016-08-29 IL IL247535A patent/IL247535B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP3129037A1 (en) | 2017-02-15 |
| WO2015155263A1 (en) | 2015-10-15 |
| EP3129037B1 (en) | 2019-11-13 |
| CA2943871A1 (en) | 2015-10-15 |
| CA2943871C (en) | 2025-05-06 |
| KR20160145058A (ko) | 2016-12-19 |
| IL247535B (en) | 2019-05-30 |
| ES2768715T3 (es) | 2020-06-23 |
| AU2015243297A1 (en) | 2016-09-29 |
| AU2015243297A2 (en) | 2016-09-29 |
| JP2017515806A (ja) | 2017-06-15 |
| CN106413726B (zh) | 2020-07-24 |
| KR102457060B1 (ko) | 2022-10-19 |
| CN106413726A (zh) | 2017-02-15 |
| AU2015243297B2 (en) | 2020-10-15 |
| JP6657115B2 (ja) | 2020-03-04 |
| IL247535A0 (en) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282985B (en) | Modified oncolytic viurs | |
| HUE062816T2 (hu) | Onkolitikus vakciniavírus | |
| DK3108000T3 (da) | Adeno-associeret virusvektor | |
| DK3393510T3 (da) | Zikavirusvaccine | |
| HRP20190442T1 (hr) | Kapsid | |
| DK3475433T3 (da) | Adenoviral vektor | |
| LT3218504T (lt) | Trijų segmentų arenavirusai kaip vakcinos vektoriai | |
| EP3374114A4 (en) | WORKBENCH | |
| DK3145949T3 (da) | Lentivirale vektorer | |
| DK3102669T3 (da) | Forbedret bacillevært | |
| EP3303621C0 (en) | SURFACE-BASED TAGMENTATION | |
| DK3234128T3 (da) | Sekventeringskontroller | |
| DK3113795T3 (da) | Rekombinante virale isfahan-vektorer | |
| DK3325631T3 (da) | Rekombinant orf-virusvektor | |
| FR3025617B1 (fr) | Architecture bi-voies | |
| DK3448879T3 (da) | Claudin-6 peptider | |
| DK3375874T3 (da) | Forbedret paramyxovirus-vektor | |
| IL247535B (en) | Poxviral oncolytic vectors | |
| EP3624825A4 (en) | RECOMBINANT ONCOLYTIC VIRUS | |
| LT3188755T (lt) | Vakcina | |
| ES2775740T8 (es) | Péptidos | |
| DE102015224551B8 (de) | Klammer | |
| DE112014006555A5 (de) | Kommutierungsschaltung | |
| GB201522317D0 (en) | Chimeric oncolytic virus | |
| UA32429S (uk) | Сокира |